First Time Loading...

Eupraxia Pharmaceuticals Inc
TSX:EPRX

Watchlist Manager
Eupraxia Pharmaceuticals Inc Logo
Eupraxia Pharmaceuticals Inc
TSX:EPRX
Watchlist
Price: 3.94 CAD 5.91% Market Closed
Updated: May 4, 2024

Wall Street
Price Targets

EPRX Price Targets Summary
Eupraxia Pharmaceuticals Inc

Wall Street analysts forecast EPRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EPRX is 14.74 CAD with a low forecast of 12.52 CAD and a high forecast of 17.33 CAD.

Lowest
Price Target
12.52 CAD
218% Upside
Average
Price Target
14.74 CAD
274% Upside
Highest
Price Target
17.33 CAD
340% Upside
Eupraxia Pharmaceuticals Inc Competitors:
Price Targets
ARQT
Arcutis Biotherapeutics Inc
130% Upside
OPK
OPKO Health Inc
233% Upside
SNSE
Sensei Biotherapeutics Inc
166% Upside
IMCR
Immunocore Holdings PLC
44% Upside
HRTX
Heron Therapeutics Inc
164% Upside
ALGEN
Genoway SA
62% Upside
XNCR
Xencor Inc
55% Upside
ALVO
Alvotech SA
17% Upside

Revenue
Forecast

Revenue Estimate
Eupraxia Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Eupraxia Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Net Income
Forecast

Net Income Estimate
Eupraxia Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-46%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is EPRX's stock price target?
Price Target
14.74 CAD

According to Wall Street analysts, the average 1-year price target for EPRX is 14.74 CAD with a low forecast of 12.52 CAD and a high forecast of 17.33 CAD.